Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1548-1556

  Dashper, Stuart G ^a   Pan, Yu ^b   Veith, Paul D ^a   Chen, Yu Yen ^a   Toh, Elena C Y ^a   Liu, Sze Wei ^a   Cross, Keith J ^a   Reynolds, Eric C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Murray Goulburn Nutritionals   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIINFECTIVE AGENT; DEXTRO PHENYLALANYLPROLYLARGINYL CHLOROMETHYL KETONE; KGP PROTEINASE; LACTOFERRIN; PROTEINASE; RGPA PROTEINASE; RGPB PROTEINASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; ENZYME ACTIVITY; ENZYME INACTIVATION; HYDROLYSIS; MASS SPECTROMETRY; PLANKTON; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN HYDROLYSIS; WHOLE CELL;

ADHESINS, BACTERIAL; AMINO ACID CHLOROMETHYL KETONES; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BIOFILMS; CATTLE; CYSTEINE ENDOPEPTIDASES; GINGIVAL CREVICULAR FLUID; KINETICS; LACTOFERRIN; MASS SPECTROMETRY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PORPHYROMONAS GINGIVALIS; PROTEASE INHIBITORS; PROTEIN BINDING; SALIVA;

EID: 84863163072     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05100-11     Document Type: Article

References (57)

1. Albandar JM, Brunelle JA, Kingman A. 1999. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J. Periodontol. 70:13-29.
2. Anderson BF, et al. 1987. Structure of human lactoferrin at 3.2-Å resolution. Proc. Natl. Acad. Sci. U. S. A. 84:1769-1773. (Pubitemid 17054094)
3. Armfield J, Roberts-Thomson K, Spencer A. 2000. Australia's health 2000, vol 7. Catalogue no. AUS 19. Australian Institute of Health and Welfare, Canberra, Australia.
4. Arnold RR, Russell JE, Champion WJ, Brewer M, Gauthier JJ. 1982. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect. Immun. 35:792-799.
5. Bhogal PS, Slakeski N, Reynolds EC. 1997. A cell-associated protein complex of Porphyromonas gingivalis W50 composed of Arg- and Lys-specific cysteine proteinases and adhesins. Microbiology 143:2485-2495. (Pubitemid 27356784)
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Brines RD, Brock JH. 1983. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion. Biochim. Biophys. Acta 759:229-235. (Pubitemid 13009058)
8. Brisson G, Britten M, Pouliot Y. 2007. Heat-induced aggregation of bovine lactoferrin at neutral pH: effect of iron saturation. Int. Dairy J. 17:617-624. (Pubitemid 46274287)
9. Chen YY, et al. 2002. CPG70 is a novel basic metallocarboxypeptidase with C-terminal polycystic kidney disease domains from Porphyromonas gingivalis. J. Biol. Chem. 277:23433-23440.
10. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
11. Cvitkovitch DG, Li YH, Ellen RP. 2003. Quorum sensing and biofilm formation in streptococcal infections. J. Clin. Invest. 112:1626-1632. (Pubitemid 38063718)
12. D'Aiuto F, et al. 2006. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am. Heart J. 151:977-984.
13. Dashper SG, et al. 2004. Hemoglobin hydrolysis and heme acquisition by Porphyromonas gingivalis. Oral Microbiol. Immunol. 19:50-56. (Pubitemid 38101504)
14. Eichinger A, et al. 1999. Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J. 18:5453-5462. (Pubitemid 29486365)
15. Ellison RT, III, Giehl TJ, LaForce FM. 1988. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56:2774-2781. (Pubitemid 18259927)
16. Farnaud S, Evans RW. 2003. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol. Immunol. 40:395-405. (Pubitemid 37244032)
17. Goulet V, Britigan B, Nakayama K, Grenier D. 2004. Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals. Infect. Immun. 72:4351-4356. (Pubitemid 38989290)
18. Guha N, et al. 2007. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am. J. Epidemiol. 166:1159-1173. (Pubitemid 350022751)
19. Holt SC, Kesavalu L, Walker S, Genco CA. 1999. Virulence factors of Porphyromonas gingivalis. Periodontol. 2000 20:168-238.
20. Hujoel PP, Drangsholt M, Spiekerman C, Weiss NS. 2003. An exploration of the periodontitis-cancer association. Ann. Epidemiol. 13:312-316. (Pubitemid 36765393)
21. Jabeen T, Sharma S, Singh N, Bhushan A, Singh TP. 2005. Structure of the zinc-saturated C-terminal lobe of bovine lactoferrin at 2.0-Å resolution. Acta Crystallogr. D Biol. Crystallogr. 61:1107-1115. (Pubitemid 43951492)
22. Kanyshkova TG, Buneva VN, Nevinsky GA. 2001. Lactoferrin and its biological functions. Biochemistry 66:1-7. (Pubitemid 33640785)
23. Kesavalu L, Holt SC, Ebersole JL. 1998. Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model. Oral Microbiol. Immunol. 13:373-377. (Pubitemid 28519461)
24. Kontani M, Kimura S, Nakagawa I, Hamada S. 1997. Adherence of Porphyromonas gingivalis to matrix proteins via a fimbrial cryptic receptor exposed by its own arginine-specific protease. Mol. Microbiol. 24:1179-1187. (Pubitemid 27293792)
25. Lamont RJ, Jenkinson HF. 1998. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62: 1244-1263. (Pubitemid 28558298)
26. Lönnerdal B. 2003. Lactoferrin, p 449-466. In Fox PF and McSweeney PL (ed), Advanced dairy chemistry, vol 1. Proteins. Kluwer Academic/ Plenum Publishers, London, United Kingdom.
27. Malkoski M, et al. 2001. Kappacin, a novel antibacterial peptide from bovine milk. Antimicrob. Agents Chemother. 45:2309-2315. (Pubitemid 32664472)
28. Maurer T, Fung HL. 2000. Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase. AAPS PharmSci. 2:E8.
29. Michaud DS, Joshipura K, Giovannucci E, Fuchs CS. 2007. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J. Natl. Cancer Inst. 99:171-175.
30. Milner P, Batten JE, Curtis MA. 1996. Development of a simple chemically defined medium for Porphyromonas gingivalis: requirement for alpha-ketoglutarate. FEMS Microbiol. Lett. 140:125-130. (Pubitemid 26228615)
31. Molloy MP, Herbert BR, Williams KL, Gooley AA. 1999. Extraction of Escherichia coli proteins with organic solvents prior to two-dimensional electrophoresis. Electrophoresis 20:701-704. (Pubitemid 29222418)
32. O'Brien-Simpson NM, Dashper SG, Reynolds EC. 1998. Histatin 5 is a substrate and not an inhibitor of the Arg- and Lys-specific proteinases of Porphyromonas gingivalis. Biochem. Biophys. Res. Commun. 250:474-478. (Pubitemid 28463904)
33. O'Brien-Simpson NM, et al. 2001. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model. Infect. Immun. 69:7527-7534. (Pubitemid 33086579)
34. O'Brien-Simpson NM, et al. 2005. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J. Immunol. 175:3980- 3989.
35. O'Brien-Simpson NM, Veith PD, Dashper SG, Reynolds EC. 2003. Porphyromonas gingivalis gingipains: the molecular teeth of a microbial vampire. Curr. Protein Pept. Sci. 4:409-426. (Pubitemid 37455911)
36. Ohashi A, et al. 2003. New functions of lactoferrin and beta-casein in mammalian milk as cysteine protease inhibitors. Biochem. Biophys. Res. Commun. 306:98-103. (Pubitemid 36629410)
37. Pan Y, Rowney P, Guo P, Hobman P. 2007. Biological properties of lactoferrin: an overview. Aust. J. Dairy Technol. 62:31-42. (Pubitemid 46833700)
38. Pathirana RD, O'Brien-Simpson NM, Veith PD, Riley PF, Reynolds EC. 2006. Characterization of proteinase-adhesin complexes of Porphyromonas gingivalis. Microbiology 152:2381-2394. (Pubitemid 44219645)
39. Pihlanto A, Korhonen H. 2003. Bioactive peptides and proteins. Adv. Food Nutr. Res. 47:175-276. (Pubitemid 137640846)
40. Rainard P. 1986. Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria. Vet. Microbiol. 11:387-392. (Pubitemid 16114003)
41. Reich E. 2001. Trends in caries and periodontal health epidemiology in Europe. Int. Dent. J. 51:392-398. (Pubitemid 33740811)
42. Shi Y, Kong W, Nakayama K. 2000. Human lactoferrin binds and removes the hemoglobin receptor protein of the periodontopathogen Porphyromonas gingivalis. J. Biol. Chem. 275:30002-30008.
43. Shimazaki K. 2000. Lactoferrin: a marvelous protein in milk? Animal Sci. J. 71:329-347.
44. Singh PK. 2004. Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. Biometals 17: 267-270. (Pubitemid 38987148)
45. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417: 552-555. (Pubitemid 34595922)
46. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25:134-144. (Pubitemid 128705944)
47. Spahr A, et al. 2006. Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch. Intern. Med. 166:554-559.
48. Stolzenberg-Solomon RZ, et al. 2003. Tooth loss, pancreatic cancer, and Helicobacter pylori. Am. J. Clin. Nutr. 78:176-181. (Pubitemid 39655263)
49. Szedlacsek SE, Duggleby RG. 1995. Kinetics of slow and tight-binding inhibitors. Methods Enzymol. 249:144-180.
50. Toh EC, et al. 2011. Porphyromonas gingivalis cysteine proteinase inhibition by kappa-casein peptides. Antimicrob. Agents Chemother. 55:1155-1161.
51. Tripos International. 2008. SYBYL 8.1. Tripos International, St. Louis, MO.
52. van Hooijdonk AC, Kussendrager KD, Steijns JM. 2000. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br. J. Nutr. 84(Suppl 1):S127-S134. (Pubitemid 32106838)
53. van Veen HA, Geerts ME, van Berkel PH, Nuijens JH. 2004. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. Eur. J. Biochem. 271:678-684. (Pubitemid 38250910)
54. Wakabayashi H, et al. 2009. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob. Agents Chemother. 53:3308-3316.
55. Wei Z, Nishimura T, Yoshida S. 2001. Characterization of glycans in a lactoferrin isoform, lactoferrin-a. J. Dairy Sci. 84:2584-2590. (Pubitemid 33609742)
56. Wen ZT, Burne RA. 2002. Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. Appl. Environ. Microbiol. 68:1196-1203. (Pubitemid 34205358)
57. Yamini S, et al. 2011. Crystal structure of C-lobe of bovine lactoferrin complexed with Nabumetone at 1.7-Å resolution. PDB ID 3TAJ. National Center for Biotechnology Information, Bethesda, MD. http://www.ncbi .nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?uid=3TAJ.